Nazeef Team Eyes Prix Rothschild

Sheikh Hamdan’s G1 Falmouth S. winner Nazeef (GB) (Invincible Spirit {Ire}) looks set to race outside Britain for the first time, with Deauville’s G1 Prix Rothschild on Aug. 2 her likely next target.

“We’re looking at the Prix Rothschild, but we are just going to look at the Nassau as well in case we can’t get to France for any reason,” confirmed the sheikh’s racing manager Angus Gold. “The first priority has always been Deauville, but she’ll probably be in the Nassau.”

He added of the 4-year-old filly, “I’m sure one day she will go over 10 furlongs, but the thinking was to stay at a mile for the time being. That does depend on the travel arrangements, though, if we are struggling to get anyone over to Deauville with her.”

Beaten only once when third on debut, the Shadwell-bred Nazeef has put together an impressive string of six victories since June 2019. Her three wins this year include the G2 Duke of Cambridge S. at Royal Ascot and she was one of six winners for Sheikh Hamdan at the meeting.

Gold continued, “We thought she’d be Group class this year, but you can only hope they win a Group 1—you don’t expect them to. We knew she had a lot more to give and she’s rewarded us in spades. She’s got ability, is very good looking and has a fantastic attitude, which counts for an awful lot. It’s a strong combination.”

The post Nazeef Team Eyes Prix Rothschild appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

Open Letter to the Industry: Bentley Combs

Last week I was disheartened to read the Maryland horsemen had relented to outside pressure to hold 2-year-old racing without Lasix. However, I saw a silver lining in the mentioning of a possible three-year study. No matter what side of the debate you fall on, we can all agree that the race-day administration of Lasix might be the most divisive issue in an industry full of divides.

In the back and forth debate over Lasix and its need, I have heard differing numbers. I have heard anti-Lasix people say between five and 10 percent of horses experience Exercise Induced Pulmonary Hemorrhaging (EIPH), commonly known as bleeding. On the pro-Lasix side I’ve heard over 50 percent. This three-year study gives us the chance to answer that debate.

We have decades of anecdotal evidence through experience at the track and through studies such as the South African study partially funded by the Grayson Jockey Club Research Foundation. That landmark study demonstrated the effectiveness of Lasix and, also importantly, showed no harm with its usage. Knowing this, the prevalence of EIPH should be the deciding factor in the administration of race-day Lasix. What if we had a large comprehensive study answering the question of prevalence of EIPH under real-world racing conditions in horses running in the United States that have not been administered Lasix on race day?

Vital to truly understanding the extent of EIPH, we must determine the numbers of horses who might not bleed through the nostrils, to where it can be observed by the naked eye, but who experience blood in the airways that is detected only by endoscopic exam. Whether visible or not, bleeding is damaging to a horse and often is progressive.

Not having the expertise to come up with the conceptual framework of a peer-reviewed study, this just seems like the most common-sense approach to me: We scope all 2-year-olds that run in a race in Maryland for the next three years. Scope them all 45 minutes to an hour post race. This would be for the simple binary ruling of yes or no. Other things will need to be recorded as well such as sex, surface, distance, weather conditions and track conditions as these things could be contributing factors.

Certainly any such study will face hurdles, including owners and trainers objecting to participation for fear of their horses being put on some sort of bleeder list. Submitting to the study would be a condition of entry. Also people’s minds can be put to rest with the condition of anonymity for the horse. The only purpose for identifying the horse post race is to confirm that the horse was in fact one that ran in that race.

Also: who will do the scoping and who will pay for this study? I think it should be the veterinarians currently working at Maryland tracks doing the endoscopic exams. Vets aren’t going to scope horses for free, so who will pay for the scoping and compiling of the data? This might be pie in the sky, but I think every industry stakeholder should make an effort to chip in for such a study because it benefits everybody and most of all our horses. This issue of prevalence of EIPH brings us to a new starting point in a conversation over Lasix based in science.

I think any owner, trainer, breeder or stakeholder who is genuinely curious and willing to learn would contribute. Such a study would give the world as a whole a chance to learn and grow.

So many decisions in this industry seem to be emotionally based. A study like this gives the industry a chance to base policy-making on Lasix on science rather than emotion.

Given the importance of such a study, the industry shouldn’t limit the scope to just Maryland. Every racing jurisdiction that has adopted a no-Lasix policy for 2-year-old racing–whether by regulatory authority or utilizing a track’s “house rules”–should launch a parallel project.

I sincerely hope the anti-Lasix camp with their numbers of between 5 and 10 percent are correct. Given my own experiences, I don’t believe the anti-Lasix camp’s numbers to be accurate (or they’re only counting horses who visibly bleed), but I don’t know for sure. A study like this would give us a clear view moving forward in our policy-making rather than the emotionally blinded view it seems we’ve been using thus far.

Kentucky-based Bentley Combs began training horses in late 2017 after serving as assistant trainer to Dallas Stewart. The Lexington product graduated from the University of Louisville’s Equine Industry Program in the College of Business and received an MBA from the University of Mississippi.

The post Open Letter to the Industry: Bentley Combs appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

Lyons Takes Long View For Even So

Ger Lyons took his second Irish Classic of the season on Saturday with the Coolmore-owned Even So (Ire) (Camelot {GB}) and is already looking forward to her 4-year-old season.

“A real plan hasn’t been made, but her real career could kick in at four because there’s a good programme for the older fillies,” he said of the three-time winner. “There’s obviously the Yorkshire Oaks, but I wouldn’t be in a rush to take on Love, without talking to connections they let all of their horses take each other on, but I don’t think I need to do that with her.

“There’s no plan at the moment for Even So—she’s out in the paddock with Yaxeni and Lemista and she’ll be there all of this week at the very least to help her get over her exertions.”

He added: “The initial thinking was to find a little prep and head for [Champions Day at] Ascot.”

Lemista (Ire) (Raven’s Pass) added to a fantastic weekend for the Lyons stable with her victory in the G2 Kilboy Estates S. over nine furlongs. The filly, who was racing in the colours of American owner Peter Brant, has Even So behind her in third when winning the G3 Park Express S. in March before racing was halted. She then bounced back to win the listed Victor McCalmont Memorial S. on June 20.

“Lemista is a great filly. It was a big decision to sell her for David Spratt,” said the trainer. “She’s winning over a trip shorter than I think is her best, and on ground quicker than I think she wants. If you could see her and Even So work on the gallops you’d be scratching your head, but they turn it on on the track. They lead the baby 2-year-olds on the gallops.”

Lyons added, “The day she won the Park Express we were speculatively black-type hunting, but Chris Hayes rode her and told us we were under-estimating her. I don’t think she’s an [Irish] St Leger type–I have Nickajack Cave for that, who won the Saval Beg. You could run Even So over a mile and six, or Yaxeni.”

A maiden winner last season, Yaxeni (Fr) (Maxios {GB}), owned by SBA Racing Ltd, which also races the smart juvenile Frenetic (Ire) (Kodiac {GB}), finished sixth in the Irish Oaks and has also been Group 3-placed this year.

 

The post Lyons Takes Long View For Even So appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

Verified by MonsterInsights